Boston Scientific: Tobin Broadens Horizons, LaViolette To Leave

Boston Scientific CEO Jim Tobin will begin managing day-to-day operations across the company now that the firm's cardiac rhythm management business is stabilized, the firm said June 3

More from Archive

More from Medtech Insight